{"id":"W4409916105","doi":"10.1158/1078-0432.ccr-24-2701","title":"A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor–Positive Breast Cancer: The BRACELET-01/PrE0113 Study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"Oncolytics Biotech; Pfizer","keywords":"Paclitaxel; Avelumab; Metastatic breast cancer; Breast cancer; Oncology; Hormone receptor; Medicine; Internal medicine; Mammary gland; Cancer; Hormone; Randomized controlled trial; Immunotherapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001710997,0.001875634,0.002336611,0.000420797,0.0003444898,0.001155034,0.001248194,0.001348019,0.008050803],"category_scores_gemma":[0.001036234,0.0008609716,0.001697931,0.0004643237,0.001045857,0.001009316,0.0003158627,0.003893487,0.001398543],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009833093,"about_ca_system_score_gemma":0.001397946,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009439331,"about_ca_topic_score_gemma":0.002911839,"domain_scores_codex":[0.9995658,0.0002379534,0.00001844008,0.00006254418,0.00004054791,0.00007470504],"domain_scores_gemma":[0.9992827,0.0001665961,0.0001777624,0.000067338,0.00003661215,0.0002690873],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9390187,0.02426613,0.000844545,0.0006043821,0.0009920722,0.00005256587,0.00005218849,0.0005852093,0.007844062,0.0001546231,0.001863591,0.0237219],"study_design_scores_gemma":[0.8875007,0.1081782,0.001829704,0.00002461214,0.000331417,0.00006278705,0.00002023485,0.0004028605,0.0005892732,0.0001036474,0.0009406515,0.00001578102],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860073,0.004283741,0.0007442772,0.0007150422,0.000448188,0.003311998,0.001442403,0.0001695628,0.002877354],"genre_scores_gemma":[0.9766504,0.004396611,0.002017172,0.001779204,0.0004340607,0.004487782,0.002619979,0.00007033876,0.007544507],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008050803,"threshold_uncertainty_score":0.0269326,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08095628293231082,"score_gpt":0.487306013923848,"score_spread":0.4063497309915372,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}